Increased immunohistochemical expression of COX-2 is associated with unfavorable prognostic factors such as a larger tumor size, more aggressive histological subtypes, higher metastatic potential to lymph nodes, and high histological grade. This evidence concerns the gene PTGS2 and neoplasm.